首页> 外文期刊>Fitoterapia >Anti-diabetic effect of American ginseng may not be linked to antioxidant activity: comparison between American ginseng and Scutellaria baicalensis using an ob/ob mice model.
【24h】

Anti-diabetic effect of American ginseng may not be linked to antioxidant activity: comparison between American ginseng and Scutellaria baicalensis using an ob/ob mice model.

机译:西洋参的抗糖尿病作用可能与抗氧化剂活性无关:使用 ob / ob 小鼠模型比较西洋参和黄S(i。Sicalellaria baicalensis)

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Antioxidants have been considered as a useful remedy in diabetes therapeutics, and thus, herbal medicines with antioxidant properties may play major role in treating diabetes. In this report, we performed a comparative study using American ginseng and Scutellaria baicalensis to test whether the anti-diabetic effect of American ginseng is associated with its antioxidant activity. We used a simple water extraction procedure to prepare American ginseng root extract (AGE) and S. baicalensis extract (SbE), and utilized these two antioxidant herbs to evaluate their anti-diabetic effect in obese diabetic ob/ob mice. HPLC analysis was used to identify major constituents in the AGE and SbE. After 12 days of daily intraperitoneal injection, AGE at 300 mg/kg showed significant effects on fasting blood glucose levels (P<0.01) and glucose tolerance test (P<0.01) compared to vehicle-treated mice. Animal body weights also reduced significantly after 12-day treatment (P<0.01). However, SbE, a very strong antioxidant extract, administered at 5-50 mg/kg (based on our previous studies without adverse events) for 12 days did not show any significant effects on blood glucose and body weight changes. No effects were shown when baicalein, an effective antioxidant constituent in SbE, was administered at 1-5 mg/kg. It appears that the anti-diabetic effect of American ginseng may not be linked to its antioxidant actions. The mechanisms of American ginseng's effects on reducing high blood glucose levels and body weight remain to be investigated in future experiments.
机译:抗氧化剂已被认为是糖尿病治疗中的有用疗法,因此,具有抗氧化特性的草药可能在糖尿病治疗中起主要作用。在本报告中,我们使用西洋参和黄i进行了比较研究,以检验西洋参的抗糖尿病作用是否与其抗氧化活性有关。我们使用简单的水提取程序来制备西洋参根提取物(AGE)和 S。黄ical提取物(SbE),并利用这两种抗氧化草药评估其对肥胖糖尿病 ob / ob 小鼠的抗糖尿病作用。 HPLC分析用于鉴定AGE和SbE中的主要成分。每天腹腔注射12天后,300 mg / kg的AGE对空腹血糖水平( P <0.01)和葡萄糖耐量测试( P <0.01)有显着影响与媒介物治疗的老鼠相比治疗12天后,动物体重也显着降低( P <0.01)。但是,SbE是一种非常强的抗氧化剂提取物,以5-50 mg / kg的剂量(根据我们之前的无不良事件的研究)给药12天,对血糖和体重变化没有明显影响。当以1-5 mg / kg的剂量施用黄ical素(一种有效的抗氧化剂成分)时,没有显示出作用。西洋参的抗糖尿病作用似乎与其抗氧化作用没有关系。西洋参降低高血糖水平和减轻体重的作用机制有待进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号